CLYM
Climb Bio
CLYM
CLYM
19 hedge funds and large institutions have $48.4M invested in Climb Bio in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $61M → $48.4M (-$12.6M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$223K | |
| 3 | +$180K | |
| 4 |
AI
Atom Investors
Austin,
Texas
|
+$9.38K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.23K |
Top Sellers
| 1 | -$484K | |
| 2 | -$92.6K | |
| 3 | -$2.61K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$716 |
| 5 |
Millennium Management
New York
|
-$186 |